INTRODUCTION
Anemia is a decrease in the oxygen carrying capacity of the blood. It can arise if the hemoglobin (Hb) concentration of the red blood cells (RBCs) or the packed cell volume of RBCs (PCV) is below the lower limit of the reference interval for the individual's age, gender, geographical location, and physiological status.
1,2 During pregnancy the total blood volume increases by about 1.5 liter. 3 The plasma volume increases more compared to red cell mass which leading to hemodilution and reduced hemoglobin concentration. This is termed physiological anemia of pregnancy. 3, 4 The World Health Organization (WHO) has suggested that anemia is present in pregnancy when Hb level is <11g/dl. It also classified anemia in pregnancy as mild (10.0-10.9g/dl), moderate (7.0-9.9g/dl), and severe (lower than 7.0g/dl) based on the level of hemoglobin concentration. 5 Anemia is a public health problem in both developed and developing countries. It affects 1.62 billion people globally, which corresponds to 24.8% of the world population. Global prevalence of anemia in pregnant women is 41.8% and the highest proportions of pregnant women affected are in Africa (57.1%). 5 Depressive symptoms during pregnancy may have devastating consequences, not only for the women, but also for the child and family. 6 Antepartum depressive and anxiety symptoms (ADS and AAS, respectively) can lead to postpartum depression. 7, 8 Lower birth weight, and premature delivery, and have a negative impact on child development. So, this study was planned to estimate the prevalence of anemia and Depression in women attending ANC clinic.
METHODS
Facility Based cross sectional study. Antenatal clinic of rural Medical College and Hospital. From June to August 2018. Pregnant females attending ANC during the study period. Purposive sampling technique. The required sample size for this study was calculated using a single population proportion formula with a 95% CI, 5% margin of error, and assumption that 21.3% of pregnant women are anemic. 9 Using Formula 4PQ/L2 and 10% nonresponse rate the required sample size was 284.
• Study tools: pretested questionnaire • Consent type: Written Informed consent • Ethical Consideration: The study was approved by Institutional Ethics Committee.
Interviewer administered structured pretested questionnaire and review of medical records were used to collect data on the sociodemographic characteristics, obstetric and gynecological, diet, and clinical characteristics of the study participants depression and anxiety. The interview and record review were conducted by two trained ANC service provider nurses at ANC clinic. About 4 ml venous blood specimens were taken from each participant in K3-EDTA tubes for the hematological examinations. Automated hematology analyzer Cell-Dyn 1800 (Abbott Laboratories Diagnostics Division, USA) was used to determine complete blood count.
Statistical analysis
Data from both questioner and laboratory were checked and cleaned for completeness and consistency and then analyzed using Statistical Package for the Social Science (SPSS) Version 20 statistical software. (Trail version). Descriptive statistics such as frequency, percentage, and mean and standard deviation were used to describe dependent and independent variables. Binary logistic regression analysis had been used to check for association between dependent and independent variables. A p-value <0.05 is considered statistically significant. Table 1 out of 284 pregnant females, 33 were anemic (11.6%) while 251 were non-anemic. Similarly, 24 (8.6%) were under depression during the time of pregnancy. The most common age group was found to be 20-40 years. Most of the females were educated. Nearly all came with the problem of blood loss. Iron and Folic acid supplementation was seen in all females of nonanemic but only 5% in anemic. This could be main factor for their low haemoglobin in our study. Table 2 it was clear the prevalence of anemia is 11.6% and depression was 8.6%. The most common age group to have anemia is 20-40 years and in depression>40 years this can be due to fact that >40 years in nearing the retirement age. This association was significant. (p<0.05) Most of the pregnant female were anemic and depressed in 3rd trimester. And this association was also significant. (p<0.05) was nearly no blood loss in females. While IFA supplementation showed drastic changes. Around 17 females who were anemic and 12 depressed were not taking IFA.
RESULTS

As per
DISCUSSION
The prevalence of anemia in the present study was 11.6% (95% CI;7.8% 14.8%).This prevalence was almost consistent with studies conducted in Awassa (15.1%), Gondar (16.6%), Debre Berhan (9.7%), Sudan (10%), Iran (13.6%), and Nakhon Sawan, Thailand (14.1%). [10] [11] [12] [13] [14] However, our finding is much lower than studies conducted in Pakistan (90.5%), India (87.2%), Malaysia (57.4%), Benin (68.3%), Nigeria (54.5%), Somali Region (56.8%), Walayita Sodo (40%), West Arsi zone (36.6%), and north western zone of Tigray (36.1%). Our result is also lower than results reported from Uganda (22.1%), Southern Ethiopia (29%), Southeast Ethiopia (27.9%) Mekelle (19.7%), and Addis Ababa (21.3%). [15] [16] [17] [18] [19] The difference may be due to geographical variation, differences in socioeconomic status, and dietary habits of the study participants. The lower finding of our study also may be due to the governments' effort to achieve Millennium Development Goals (MDGs) since improving maternal health is one of the eight MDGs and targeted to reduce the maternal mortality ratio by threequarters in 2015. Only the association of gestational age (trimester) and iron/folic acid supplementations did reach to a statistically significance level. Pregnant women in second and third trimester were more likely to be anemic when compared to pregnant women in first trimester. This might be due to the higher maternal plasma volume increments (40-50%) relative to red cell mass (20-30%) and accounts for the fall in hemoglobin concentration. 18 The risk of developing anemia increased in pregnant women who did not receive iron supplementation during pregnancy when compared to those who received iron supplementation. This may be due to iron deficiencies developing during pregnancy because of the increased iron requirements to supply the expanding blood volume of the mother and the rapidly growing fetus and placenta.
CONCLUSION
This study has revealed that the prevalence of Anemia and Depression in pregnancy was low (11.62%) (8.6%) compared to the findings of other areas of India. Gestational age (trimester) and iron/folic acid supplementation were statistically associated with anemia in this study. Therefore, health education to create awareness about the importance of early booking for antenatal care are recommended to reduce anemia and counselling must be done in each session to reduce depression.
